Cent Eur J Public Health 2023, 31(2):90-96 | DOI: 10.21101/cejph.a7631

Analysis of impact of nosocomial infections on cost of patient hospitalisation

Patricia Blatnik, Štefan Bojnec
Department of Economics, Faculty of Management, University of Primorska, Koper, Slovenia

Objectives: The scale of the economic problem of the occurrence of nosocomial infections and the resulting high additional costs of treatment can only be assessed using economic analyses. The aim of the study was to analyse the impact of a nosocomial infection in a patient in the treatment process and the direct costs of patient hospitalisation. The article contributes to a cost analysis, which is a relevant basis for adopting effective solutions and decisions on the introduction of new programmes and measures to reduce nosocomial infections and associated costs.

Methods: In the first phase of the micro-economic analysis, we analysed the course of hospitalisation of a non-colonised patient treated in an ordinary hospital room. In the second phase, we analysed the process of hospitalisation of a patient who developed a nosocomial infection and was transferred to an isolation room. The difference in cost of both types of treatment allowed us to carry out an economic analysis to estimate the direct costs of nosocomial infection, which are not related to the initial diagnosis of the patient but only to the patient hospitalisation. To calculate the individual types of direct costs of both alternative treatments, we first used the process flow diagram method, which then enabled us to analyse the impact of the occurrence of nosocomial infection on the efficiency and costs of the hospital.

Results: The results showed that the total direct cost of hospitalisation of a non-colonised patient was 1,317.58 euro per day, and the direct cost of hospitalisation of a patient with a nosocomial infection was 2,268.14 euro per day of hospitalisation.

Conclusions: We found that reducing nosocomial infections would have a significant impact on the savings or reduction in healthcare costs associated with a different work process for patients in isolation. It would save 950.56 euro per patient for each day of hospitalisation for individual treatment of a patient hospitalised in an isolation room as consequence of a nosocomial infection.

Klíčová slova: economic evaluation, costs, nosocomial infections, isolation, general hospitals

Vloženo: 10. říjen 2022; Revidováno: 22. duben 2023; Přijato: 22. duben 2023; Zveřejněno: 30. červen 2023  Zobrazit citaci

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Blatnik P, Bojnec Š. Analysis of impact of nosocomial infections on cost of patient hospitalisation. Cent Eur J Public Health. 2023;31(2):90-96. doi: 10.21101/cejph.a7631. PubMed PMID: 37451240.
Stáhnout citaci

Reference

  1. Wenzel RP. Health care-associated infections: major issues in the early years of the 21st century. Clin Infect Dis. 2007;45 Suppl 1:S85-8.
  2. Tchouaket Nguemeleu E, Beogo I, Sia D, Kilpatrick K, Séguin C, Baillot A, et al. Economic analysis of healthcare-associated infection prevention and control interventions in medical and surgical units: systematic review using a discounting approach. J Hosp Infect. 2020;106(1):134-54. Přejít k původnímu zdroji... Přejít na PubMed...
  3. Forrester JD, Maggio PM, Tennakoon L. Cost of health care-associated infections in the United States. J Patient Saf. 2022;18(2):e477-9. Přejít k původnímu zdroji... Přejít na PubMed...
  4. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections. Am J Infect Control. 1988;16(3):128-40. Přejít k původnímu zdroji... Přejít na PubMed...
  5. Khan HA, Baig FK, Mehboob R. Nosocomial infections: epidemiology, prevention, control and surveillance. Asian Pac J Trop Biomed. 2017;7(5):478-82. Přejít k původnímu zdroji...
  6. Doshi RK, Patel G, Mackay R, Wallach F. Healthcare-associated infections: epidemiology, prevention, and therapy. Mt Sinai J Med. 2009;76(1):84-94. Přejít k původnímu zdroji... Přejít na PubMed...
  7. Geffers C, Sohr D, Gastmeier P. Mortality attributable to hospital-acquired infections among surgical patients. Infect Control Hosp Epidemiol. 2008;29(12):1167-70. Přejít k původnímu zdroji... Přejít na PubMed...
  8. Pittet D, Tarara D, Wenzel RP. Nosocomial bloodstream infection in critically ill patients. Excess length of stay, extra costs, and attributable mortality. JAMA. 1994;271(20):1598-601. Přejít k původnímu zdroji... Přejít na PubMed...
  9. Hillman D, Cuningham B, Weisenbach T, Figg F. Breaking the bloodstream infection connection: utilizing a swab containing chlorhexidine gluconate (3.15%) and isopropyl alcohol (70%), Chlorascrub. Am J Infect Control. 2012;40(5):e145. Přejít k původnímu zdroji...
  10. European Centre for Disease Prevention and Control. Annual Epidemiological Report on Communicable Diseases in Europe 2008: report on the state of communicable diseases in the EU and EEA/EFTA countries [Internet]. Stockholm: ECDC; 2008 [cited 2022 Feb 10]. Available from: http://ecdc.europa.eu/en/publications/Publications/0812_SUR_Annual_Epidemiological_Report_2008.pdf.
  11. Vincent JL, Rello J, Marshall J, Silva E, Anzueto A, Martin CD, et al. International study of the prevalence and outcomes of infection in intensive care units. JAMA. 2009;302(21):2323-9. Přejít k původnímu zdroji... Přejít na PubMed...
  12. Klevens RM, Edwards JR, Richards CL Jr, Horan TC, Gaynes RP, Pollock DA, et al. Estimating health care-associated infections and deaths in U.S. hospitals, 2002. Public Health Rep. 2007;122(2):160-6. Přejít k původnímu zdroji... Přejít na PubMed...
  13. Divatia JV, Pulinilkunnathil JG, Myatra SN. Nosocomial infections and ventilator-associated pneumonia in cancer patients. In: Nates JL, Price KJ, editors. Oncologic critical care. Cham: Springer; 2019. p. 1419-39. Přejít k původnímu zdroji...
  14. Klavs I, Serdt M, Korošec A, Lejko Zupanc T, Pečavar B; SNHPS III. Prevalence of and factors associated with healthcare-associated infections in Slovenian acute care hospitals: results of the third national survey. Zdr Varst. 2019;58(2):62-9. Přejít k původnímu zdroji... Přejít na PubMed...
  15. Suetens C, Latour K, Kärki T, Ricchizzi E, Kinross P, Moro ML, et al. Prevalence of healthcare-associated infections, estimated incidence and composite antimicrobial resistance index in acute care hospitals and long-term care facilities: results from two European point prevalence surveys, 2016 to 2017. Euro Surveill. 2018;23(46):1800516. doi: 10.2807/1560-7917.ES.2018.23.46.1800516. Přejít k původnímu zdroji... Přejít na PubMed...
  16. Martone WJ, Jarvis WR, Culver DH, Haley RW. Incidence and nature of endemic and epidemic nosocomial infections. In: Bennett JV, Brachman PS, editors. Hospital infections. Boston: Little, Brown and Company, 1992. p. 577-96.
  17. Douglas Scott II. The direct medical costs of HealthCare associated infections in U.S. hospitals and the benefits of prevention [Internet]. Atlanta: Centers for Disease Control and Prevention; 2009 [cited 2022 Feb 10]. Available at: http://www.cdc.gov/HAI/pdfs/hai/Scott_CostPaper.pdf.
  18. Rennert-May E, Conly J, Leal J, Smith S, Manns B. Economic evaluations and their use in infection prevention and control: a narrative review. Antimicrob Resist Infect Control. 2018;7:31. doi: 10.1186/s13756-018-0327-z. Přejít k původnímu zdroji... Přejít na PubMed...
  19. Stone PW. Economic burden of healthcare-associated infections: an American perspective. Expert Rev Pharmacoecon Outcomes Res. 2009;9(5):417-22. Přejít k původnímu zdroji... Přejít na PubMed...
  20. Samuelson P, Nordhaus W. Economics. 19th ed. New York: McGraw Hill; 2009.
  21. Benenson S, Cohen MJ, Schwartz C, Revva M, Moses AE, Levin PD. Is it financially beneficial for hospitals to prevent nosocomial infections? BMC Health Serv Res. 2020;20(1):653. doi: 10.1186/s12913-020-05428-7. Přejít k původnímu zdroji... Přejít na PubMed...
  22. O'Leary MC, Hassmiller Lich K, Frerichs L, Leeman J, Reuland DS, Wheeler SB. Extending analytic methods for economic evaluation in implementation science. Implement Sci. 2022;17:27. doi: 10.1186/s13012-022-01192-w. Přejít k původnímu zdroji... Přejít na PubMed...
  23. Haley RW, Schaberg DR, Van Allmen SD, McGowen JE. Estimating the extra charges and prolongation of hospitalization due to nosocomial infections: a comparison of methods. J Infect Dis. 1980;141(2):248-57. Přejít k původnímu zdroji... Přejít na PubMed...
  24. Yalcin AN, Hayran M, Unal S. Economic analysis of nosocomial infections in a Turkish University Hospital. J Chemother. 1997;9(6):411-4. Přejít k původnímu zdroji... Přejít na PubMed...
  25. Andersen BM. Economic consequences of hospital infections in a 1000 bed university hospital in Norway. Infect Control Hosp Epidemiol. 1998;19(10):805-7. Přejít k původnímu zdroji... Přejít na PubMed...
  26. Jarvis WR. Selected aspects of the socioeconomic impact of nosocomial infections: morbidity, mortality, cost, and prevention. Infect Control Hosp Epidemiol. 1996;17(8):552-7. Přejít k původnímu zdroji...
  27. Manoukian S, Stewart S, Graves N, Mason H, Robertson C, Kennedy S, et al. Bed-days and costs associated with the inpatient burden of healthcare-associated infection in the UK. J Hosp Infect. 2021;114:43-50. Přejít k původnímu zdroji... Přejít na PubMed...
  28. Perencevich EN, Sands KE, Cosgrove SE, Guadagnoli E, Meara E, Platt R. Health and economic impact of surgical site infections diagnosed after hospital discharge. Emerg Infect Dis. 2003;9(2):196-203. Přejít k původnímu zdroji... Přejít na PubMed...
  29. Umscheid CA, Mitchell MD, Doshi JA, Agarwal R, Williams K, Brennan PJ. Estimating the proportion of healthcare-associated infections that are reasonably preventable and the related mortality and costs. Infect Control Hosp Epidemiol. 2011;32(2):101-14. Přejít k původnímu zdroji... Přejít na PubMed...
  30. Plowman R, Graves N, Griffin MA, Roberts JA, Swan AV, Cookson B, et al. The rate and cost of hospital-acquired infections occurring in patients admitted to selected specialties of a district general hospital in England and the national burden imposed. J Hosp Infect. 2001;47(3):198-209. Přejít k původnímu zdroji... Přejít na PubMed...
  31. Currie E, Maynard A. The economics of hospital acquired infection. 1st ed. York, UK: University of York; 1989.
  32. Haley RW. Preliminary cost-benefit analysis of hospital infection control programs (The SENIC Project). In: Daschner F, editor. Proven and unproven methods in hospital infection control. Stuttgart: Gustav, Fisher and Verlag; 1978. p. 93-6.
  33. Wenzel R. The economics of nosocomial infection. J Hosp Infect. 1995;31(2):79-87. Přejít k původnímu zdroji... Přejít na PubMed...
  34. Cohen DR. Economic issues in infection control. J Hosp Infect. 1984;5 Suppl A:17-25. Přejít k původnímu zdroji... Přejít na PubMed...
  35. White LF, Dancer SJ, Robertson C, McDonald J. Are hygiene standards useful in assessing infection risk? Am J Infect Control. 2008; 36(5):381-4. Přejít k původnímu zdroji... Přejít na PubMed...
  36. Wilson APR, Livermore DM, Otter JA, Warren RE, Jenks P, Enoch DA, et al. Prevention and control of multi-drug-resistant Gram-negative bacteria: recommendations from a Joint Working Party. J Hosp Infect. 2016;92 Suppl 1:1-44. Přejít k původnímu zdroji... Přejít na PubMed...
  37. Carling PC, Huang SS. Improving healthcare environmental cleaning and disinfection. Infect Control Hosp Epidemiol. 2013;34(5):507-13. Přejít k původnímu zdroji... Přejít na PubMed...
  38. Vickery K, Deva A, Jacombs A, Allan J, Valente P, Gosbell IB. Presence of biofilm containing viable multiresistant organisms despite terminal cleaning on clinical surfaces in an intensive care unit. J Hosp Infect. 2012;80(1):52-5. Přejít k původnímu zdroji... Přejít na PubMed...
  39. Otter JA, Yezli S, French GL. The role played by contaminated surfaces in the transmission of nosocomial pathogens. Infect Control Hosp Epidemiol. 2011;32(7):687-99. Přejít k původnímu zdroji... Přejít na PubMed...
  40. Weber DJ, Anderson D, Rutala WA. The role of the surface environment in healthcare-associated infections. Curr Opin Infect Dis. 2013;26(4):338-44. Přejít k původnímu zdroji...
  41. Rutala WA, Gergen MF, Weber DJ. Room decontamination with UV radiation. Infect Control Hosp Epidemiol. 2010;31(10):1025-9. Přejít k původnímu zdroji... Přejít na PubMed...
  42. Wong T, Woznow T, Petrie M, Murzello E, Muniak A, Kadora A, et al. Postdischarge decontamination of MRSA, VRE, and Clostridium difficile isolation rooms using 2 commercially available automated ultraviolet-C-emitting devices. Am J Infect Control. 2016;44(4):416-20. Přejít k původnímu zdroji... Přejít na PubMed...
  43. Casini B, Tuvo B, Cristina ML, Spagnolo AM, Totaro M, Baggiani A, et al. Evaluation of an ultraviolet C (UVC) light-emitting device for disinfection of high touch surfaces in hospital critical areas. Int J Environ Res Public Health. 2019;16(19):3572. doi: 10.3390/ijerph16193572. Přejít k původnímu zdroji... Přejít na PubMed...